Biogen
Search results
As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients.
Ionis: A force for life. We are guided by world-class scientists and business leaders whose drive and passion to innovate is matched only by their commitment to deliver first-in-class and best-in-class medicines to the patients who need them. View 2023 Corporate Responsibility Report ».
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.
With approved first-in-class medicines and up to a dozen more in mid- or late-stage development, our therapeutic breakthroughs are poised to transform lives.
5 days ago · Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing.
May 7, 2019 · IONIS-FB-L Rx, also known as RG6299, is an investigational LIgand-Conjugated Antisense (LICA) medicine designed to inhibit the production of complement factor B (FB) and the alternative complement pathway.
Ionis is guided by world-class scientists and business leaders whose passion to innovate is matched only by their commitment to deliver transformational medicines to patients who need them.
Dec 22, 2023 · The U.S. Food and Drug Administration (FDA) on Thursday approved Ionis Pharmaceuticals (IONS.O) and partner AstraZeneca's (AZN.L) drug to treat nerve damage caused by a life-shortening rare...
Ionis’ antisense technology. With RNA as the target that forms the basis of our novel drug discovery platform, we are tackling the most difficult to treat diseases with a focus on neurology and cardiometabolic diseases.
Get the latest Ionis Pharmaceuticals Inc (IONS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
